Sun Y, Yin Z, Li S, Wu L, et al. Losartan rewires the tumor-immune microenvironment and suppresses IGF-1 to overcome resistance to chemo-immunotherapy in ovarian cancer. Br J Cancer 2024 Oct 5. doi: 10.1038/s41416-024-02863.
PMID: 39369055